Telomir Pharmaceuticals (TELO) Current Assets (2022 - 2026)
Telomir Pharmaceuticals (TELO) posted Current Assets of $7.3 million for Q4 2025, down 0.82% sequentially from $7.4 million in Q3 2025, and up 454.48% YoY from $1.3 million in Q4 2024.
Telomir Pharmaceuticals (TELO) Current Assets (2022 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Current Assets for 4 years, with the latest figure at $7.3 million in Q4 2025.
- Quarterly Current Assets rose 454.48% year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 million (up 454.48% YoY) and the FY2025 annual result came in at $7.3 million, up 454.48% from the prior year.
- Current Assets fell to $7.3 million in Q4 2025 per TELO's latest filing, from $7.4 million in the prior quarter.
- Over five years, Current Assets peaked at $7.4 million in Q3 2025 and troughed at $48730.0 in Q4 2022.
- A 4-year average of $2.5 million and a median of $1.2 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets jumped 793.14% in 2023, then sank 85.98% in 2025.
- Over 4 years, Current Assets stood at $48730.0 in 2022, then surged by 793.14% to $435225.0 in 2023, then surged by 204.21% to $1.3 million in 2024, then jumped by 454.48% to $7.3 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $7.3 million, $7.4 million, and $829611.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Telomir Pharmaceuticals | 68.14 Mn | 68.14 Mn | - | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.37 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | 829,611.00 |
| Mar 31, 2025 | 491,188.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 435,225.00 |
| Dec 31, 2022 | 48,730.00 |